Search clinical trials for: Sibutramine Hydrochloride Monohydrate

Total 7781 results

Eisai Limited

Completed

A Comparative Study of KES524 in Patients With Obesity Disease

Obesity

Japan
Abbott

Completed

A Phase IV, Multi-Center, Open-Label Trial of Sibutramine in Combination With a Hypocaloric Diet in Obese and Overweight Thai Subjects.

Obesity

United States
Laboratorios Silanes S.A. de C.V.

Unknown

Sibutramine-metformin Combination Versus Sibutramine and Metformin Monotherapy in Obese Patients

Obesity

Mexico
Abbott

Completed

A Long Term Study of Sibutramine and the Role of Obesity Management in Relation to Cardiovascular Disease in Overweight and Obese Patients (SCOUT)

Obesity

United States
GlaxoSmithKline

Completed

A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese Subjects

Obesity

United Kingdom
Merck Sharp & Dohme LLC

Completed

A Functional Magnetic Resonance Imaging (fMRI) Study in Overweight and Obese Men (0000-103)

Obesity
Abbott

Terminated

Study to Examine the Longer-Term Efficacy and Safety of Sibutramine Hydrochloride in Obese Subjects

Obesity | Weight Loss
Mayo Clinic

Completed

Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

Obesity | Overweight

United States
Abbott

Completed

A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder

Obesity | Binge Eating Disorder
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Completed

The Tolerance, Pharmacokinetics of Jaktinib in Healthy Volunteers

Healthy Volunteers

China
Abbott

Completed

A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.

Obesity
Mayo Clinic
National Institutes of Health (NIH)

Completed

Weight Loss in Response to Sibutramine (MERIDIA) is Influenced by the Inherited Genes

Obesity

United States
Promomed, LLC

Completed

Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity

Obesity

Russian Federation
Pfizer

Completed

A Study Of 6-Month Duration To Evaluate The Weight Loss Effect Of Various Doses Of CP-945,598 In Obese Subjects

Obesity

United States
Eurofarma Laboratorios S.A.

Not yet recruiting

A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight (UNLIMITED)

Obesity | Overweight

Brazil
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...

Completed

Treatment of Binge Eating in Obese Patients in Primary Care

Obesity | Binge Eating

United States
Dynamical Business and Science Society - DBSS International...
CES University; INDEPORTES Antioquia

Completed

Creatine Monohydrate Versus Creatine Hydrochloride on Strength and Body Composition in Elite Team-Sport Athletes (CrM_CrHCl)

Healthy Lifestyle

Colombia
Hippocration General Hospital

Completed

Effect of Diet Plus Sibutramine on Hormonal and Metabolic Features in Overweight and Obese Women With PCOS

Obesity | Polycystic Ovary Syndrome

Greece
Laval University

Completed

Sibutramine Versus Continuous Positive Airway Pressure (CPAP)in Obstructive Sleep Apnea (OSA) Patients

Hypertension | Obesity | Obstructive Sleep Apnea
University of Sao Paulo General Hospital
Fundação de Amparo à Pesquisa do Estado de São Paulo

Completed

Effects of Weight Loss in Obese Difficult-to-treat Asthmatics

Obesity | Asthma | Weight Loss

Brazil
Denovo Biopharma LLC

Completed

A Study of LY2140023 in Healthy Males and Females

Healthy Volunteers

United Kingdom
Brooke Army Medical Center
59th Medical Wing

Unknown

"Efficacy in Adolescents of Continued Behavior Modification Following a Six Month Sibutramine-based Weight Management Intervention" (AOS)

Obesity

United States
National Institute of Diabetes and Digestive and...

Completed

Adolescent Weight Management Study

Protocol #1:Behavioral Therapy + Placebo or Sibutramine | Protocol #2: Behavioral Therapy + Meal Replacement or Conventional Food
Yale University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care

Obesity | Binge Eating

United States
University of Tennessee
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates (SUCCESS)

Heart Diseases | Cardiovascular Diseases | Obesity

United States
Inje University

Completed

Effects of Clopidogrel and Clarithromycin on the Oral Disposition of Sibutramine in Healthy Subjects (sibu)

Healthy
New York State Psychiatric Institute
AstraZeneca

Terminated

Studying the Effects of Sibutramine on Eating Behavior

Obesity

United States
University of Southern California
National Cancer Institute (NCI)

Withdrawn

Continuous Infusion of Ropivacaine Hydrochloride in Reducing Pain After Surgery in Patients With Bladder Cancer

Bladder Carcinoma | Post-operative Pain

United States
Cambridge University Hospitals NHS Foundation Trust
GlaxoSmithKline; University of Cambridge; Royal Brompton & Harefield NHS Foundation... and other collaborators

Completed

Losmapimod in Chronic Obstructive Pulmonary Disease Patients Stratified by Fibrinogen. (EVOLUTION)

Chronic Obstructive Pulmonary Disease

United Kingdom
Pennington Biomedical Research Center
Louisiana Office of Group Benefits

Terminated

LOSS- Louisiana Obese Subjects Study (LOSS)

Obesity

United States
Abbott

Completed

Efficacy and Safety Study of Sibutramine in Overweight Non-Diabetic Malaysian Population

Obesity
Estetra

Recruiting

Estetrol for the Treatment of Female Sexual Arousal Disorder in Postmenopausal Women

Sexual Dysfunction, Physiological

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

Testing the Addition of Ruxolitinib to the Usual Treatment (Tyrosine Kinase Inhibitors) for Chronic Myeloid Leukemia

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

United States
Leadiant Biosciences, Inc.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and other collaborators

Active, not recruiting

Multi-Center Study of ManNAc for GNE Myopathy (MAGiNE)

GNE Myopathy

United States
Biologische Heilmittel Heel GmbH

Completed

Explorative Efficacy Profile of Neurexan® in an Experimental Acute Stress Setting in Healthy Subjects (NEUPRO-DB)

Acute Stress Reaction

Germany
Prescient Therapeutics, Ltd.
VioQuest Pharmaceuticals

Completed

Phase I Study of Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Subjects With Metastatic Cancer

Cancer

United States
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)

Recruiting

Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Par Pharmaceutical, Inc.
Anapharm

Completed

Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Nastech Pharmaceutical Company, Inc.

Completed

A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects

Obesity

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions

Healthy

United States
Eli Lilly and Company

Completed

The Assessment of a Weight-Gain Agent for the Treatment of Olanzapine-Associated Anti-Obesity Agent in Patients With Schizophrenia, Schizophreniform Disorder, Schizoaffective Disorder, and Bipolar I Disorder

Psychotic Disorders | Schizophrenia | Bipolar Disorder

United States
Prescient Therapeutics, Ltd.
VioQuest Pharmaceuticals

Completed

Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies

Leukemia | Hematologic Malignancies

United States
NEURALIS s.a.

Active, not recruiting

Estetrol (E4) for the Treatment of Patients With Confirmed SARS-COV-2 Infection

Covid19

Belgium, Hungary, Russian Federation, Poland
Eli Lilly and Company

Terminated

A Weight Loss Study in Overweight Men and Women

Obesity

United States
AstraZeneca

Completed

A Study to Examine the Safety, Tolerability, and Body Weight Effect of Pramlintide Alone and in Combination With Oral Antiobesity Agents in Overweight and Obese Subjects

Obesity | Overweight

United States
Sidney Kimmel Cancer Center at Thomas Jefferson...

Active, not recruiting

Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery

Larynx | Oral Cavity | LIP | Pharynx

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting Conditions

Healthy

United States
National Cancer Institute (NCI)

Active, not recruiting

Gemcitabine Hydrochloride, Dasatinib, and Erlotinib Hydrochloride in Treating Patients With Pancreatic Cancer That Is Metastatic or Cannot Be Removed by Surgery

Metastatic Pancreatic Adenocarcinoma | Recurrent Pancreatic Carcinoma | Stage III Pancreatic Cancer AJCC v6 and v7 | Stage IV Pancreatic Cancer AJCC v6 and v7

United States
Gachon University Gil Medical Center

Completed

Assess the Additional Weight Loss Effect of Orlistat Used in Combination With Sibutramine

Obesity

Korea, Republic of
Eli Lilly and Company

Active, not recruiting

A Study in Recurrent Glioblastoma (GB)

Glioblastoma

United States, Germany, Spain, Belgium, Italy, Australia, Canada, France, Poland

Search clinical trials for: Sibutramine Hydrochloride Monohydrate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations